5
5

Drug Origin Transparency Act of 2026

4/30/2026, 6:17 PM

Summary of Bill HR 8339

The bill titled "To amend the Federal Food, Drug, and Cosmetic Act to enhance drug manufacturing amount information reporting, and for other purposes" was introduced in the 119th Congress as H.R. 8339 on April 16, 2026. The bill's main focus is on improving drug manufacturing amount information reporting under the Federal Food, Drug, and Cosmetic Act, with additional provisions aimed at achieving other goals specified within the bill's text.

Current Status of Bill HR 8339

Bill HR 8339 is currently in the status of Bill Introduced since April 16, 2026. Bill HR 8339 was introduced during Congress 119 and was introduced to the House on April 16, 2026.  Bill HR 8339's most recent activity was Referred to the House Committee on Energy and Commerce. as of April 16, 2026

Bipartisan Support of Bill HR 8339

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
3
Democrat Cosponsors
1
Republican Cosponsors
2
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 8339

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 8339

To amend the Federal Food, Drug, and Cosmetic Act to enhance drug manufacturing amount information reporting, and for other purposes.
To amend the Federal Food, Drug, and Cosmetic Act to enhance drug manufacturing amount information reporting, and for other purposes.

Comments

Salma Ross profile image

Salma Ross

911

1 month ago

I fully support the United States HR Bill 8339 to enhance drug manufacturing amount information reporting. This bill is crucial in ensuring the safety and effectiveness of medications for all Americans. By requiring manufacturers to report accurate information on drug production, we can better monitor and regulate the pharmaceutical industry. As a 61 year old woman, I believe this bill will directly impact my health and well-being by providing me with more transparency and confidence in the medications I take. It is important to prioritize the safety of consumers, and this bill is a step in the right direction. #HRBill8339 #DrugSafety #HealthcareReform